Summary

This report describes the antimicrobial susceptibility of: (i) a sample (approximately 20%) of non-typhoidal Salmonella from 2019 only, (ii) all internationally recognised multidrug-resistant Salmonella referred between 2017 and 2019, and (iii) all typhoidal Salmonella referred between 2017 and 2019